ANO1 and Stroke: To assess whether TMEM16A inhibition confers neuroprotection in a mouse model of stroke that incorporates a major risk factor for stroke, namely aging, we performed approximately 15 minutes of bilateral CCAO in 15-month-old mice followed by 6 hours of reperfusion (see Supplemental Figure 4B for in vivo setup).